|
Real-time Estimate
Cboe BZX
08:11:23 02/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.900 USD | -0.20% |
|
+1.48% | +27.88% |
| 25/08 | BioCryst Pharmaceuticals Announces Approval Of ORLADEYO For Pediatric HAE Patients In Japan | CI |
| 25/08 | BioCryst Pharmaceuticals Gets Japan Approval for Orladeyo in Young Children | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.20% | +1.48% | +13.22% | +19.60% | +27.88% | +20.33% | +41.49% | -37.30% | +137.50% | 253.49Cr | |
| -0.25% | -4.10% | +20.22% | +54.42% | +70.34% | +38.38% | +92.61% | +16.28% | - | 6.82TCr | |
| +1.90% | +0.65% | +25.09% | +30.17% | +26.03% | +49.08% | +90.23% | +208.33% | +6,253.02% | 6.42TCr | |
| +1.69% | -1.13% | +24.92% | +18.56% | -29.34% | -15.36% | +366.36% | +320.59% | +823.27% | 2.65TCr | |
| +2.33% | -7.67% | +12.66% | +16.59% | +9.17% | +3.29% | -14.81% | -68.37% | - | 2.56TCr | |
| +1.89% | +1.02% | +18.15% | +41.21% | +7.60% | +32.02% | -18.10% | -28.77% | +107.91% | 1.99TCr | |
| -6.09% | -12.08% | +23.58% | +51.06% | +209.18% | +226.11% | +375.00% | +1,801.66% | +854.21% | 1.71TCr | |
| +0.65% | -5.28% | +3.40% | +22.15% | +25.70% | -1.12% | +534.90% | - | - | 1.49TCr | |
| -0.05% | +1.98% | +3.90% | +17.86% | +30.53% | +53.87% | +156.89% | +182.24% | +395.75% | 1.41TCr | |
| +0.05% | +0.82% | +12.71% | +19.97% | -6.71% | +24.57% | +194.46% | +547.22% | +4,476.87% | 1.24TCr | |
| +0.01% | -6.81% | -3.44% | +17.27% | +25.09% | +223.40% | +196.29% | +20.19% | +1,061.54% | 1.17TCr | |
| +1.09% | -0.09% | +8.99% | -4.33% | -18.71% | -40.36% | +805.56% | +90.07% | +113.79% | 1.13TCr | |
| -0.61% | -9.77% | -6.53% | +0.78% | +12.46% | +44.01% | +103.24% | +113.19% | +589.77% | 992.63Cr | |
| +1.11% | +0.59% | +14.80% | +29.61% | +33.18% | +94.71% | +20.49% | +130.84% | - | 904.88Cr | |
| +0.83% | -2.36% | +12.66% | +11.41% | +306.82% | +238.45% | +451.71% | -30.44% | - | 834.09Cr | |
| -1.66% | -6.75% | -8.05% | +26.21% | +166.45% | +424.89% | +485.94% | -53.13% | -44.13% | 780.34Cr | |
| -2.58% | -4.82% | -2.43% | +21.62% | +4.18% | -7.25% | +253.08% | +275.30% | - | 726.41Cr | |
| -2.45% | +3.14% | +0.67% | -21.76% | -49.19% | - | - | - | - | 683.46Cr | |
| -0.01% | -3.95% | -6.09% | -3.79% | +1.80% | +12.61% | +53.43% | +11.81% | +163.76% | 684.36Cr | |
| -0.04% | -6.43% | +22.53% | +25.74% | +27.54% | +69.63% | +830.13% | +44.76% | - | 680.66Cr | |
| Average | -0.17% | -3.84% | +9.55% | +19.72% | +44.00% | +78.49% | +264.15% | +196.91% | +1,244.44% | 1.76TCr | |
| Weighted average by Cap. | +0.32% | -3.39% | +15.11% | +28.53% | +41.88% | +58.96% | +198.07% | +200.50% | +2,555.11% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
